Concepedia

Karen DiDonato

KD

Statistics

Publications

14

Citations

809

H-Index

13

Active since

2006

Affiliations

AcelRx Pharmaceuticals (United States)(Current)

Vivus (United States)

CFD Research Corporation (United States)

Johns Hopkins University

Urology San Antonio

Karen DiDonato is an author at AcelRx Pharmaceuticals (United States) specializing in medicine, pharmacology, and clinical pharmacology.

Publications per year

2006–2019

14

Publications

14

A Randomized, Double-Blind, Placebo-Controlled Study of an Oral, Extended-Release Formulation of Phentermine/Topiramate for the Treatment of Obstructive Sleep Apnea in Obese Adults

David Winslow, Charles H. Bowden, Karen DiDonato et al. · SLEEP · 2012 · 158 citations · Full text

, , +17

The StarClose® vascular closure system: Interventional results from the CLIP study

James Hermiller, Charles A. Simonton, Tomoaki Hinohara et al. · Catheterization and Cardiovascular Interventions · 2006 · 106 citations

, , +12

A Phase 3, Placebo Controlled Study of the Safety and Efficacy of Avanafil for the Treatment of Erectile Dysfunction After Nerve Sparing Radical Prostatectomy

John P. Mulhall, Arthur L. Burnett, Run Wang et al. · The Journal of Urology · 2012 · 105 citations

, , +13

A Randomized, Double-Blind, Placebo-Controlled Evaluation of the Safety and Efficacy of Avanafil in Subjects with Erectile Dysfunction

Irwin Goldstein, Andrew McCullough, LeRoy Jones et al. · The Journal of Sexual Medicine · 2012 · 104 citations

, , +6

Selectivity of Avanafil, a PDE5 Inhibitor for the Treatment of Erectile Dysfunction: Implications for Clinical Safety and Improved Tolerability

Run Wang, Arthur L. Burnett, Warren Heller et al. · The Journal of Sexual Medicine · 2012 · 80 citations

, , +10

1–5 of 14